OSCE Revision Respiratory Mark Woodhead Honorary Clinical Professor

OSCE Revision Respiratory Mark Woodhead Honorary Clinical Professor of Respiratory Medicine

BREATHLESSNESS • Respiratory

BREATHLESSNESS • • • Respiratory Cardiac Haematological Neurological Psychiatric

BREATHLESSNESS Pattern Age / duration Precipitants and relievers Severity Associated symptoms Exacerbations

BREATHLESSNESS Pattern Diurnal variation (asthma) Sleep disturbance (asthma) Nocturnal worsening (most causes!) Orthopnoea (LVF, COPD, Obesity…) Paroxysmal nocturnal dyspnoea (LVF)

BREATHLESSNESS Age / duration Age < 30 - asthma, bronchiectasis, psychological (COPD unlikely) Age > 50 - COPD, (asthma), cardiac Present since childhood asthma (bronchiectasis) Present only since 40 s - COPD Recent onset – pneumonia, PVTE, pneumothorax Non-smoker – asthma, Smoker – (asthma) or COPD

BREATHLESSNESS Precipitants and relievers Worse in summer – asthma Worse in winter – most things! Animals, specific irritants – asthma Occupation – specific sensitiser (asthma) or just effort? Risks for PVTE Effort – most causes

BREATHLESSNESS Severity At rest (talking) Effort – how much, distance, stairs ADLs Work Exacerbations – frequency, times in hospital, ever ICU

BREATHLESSNESS Associated symptoms Sputum > 3/12 of year, in consecutive years – COPD, bronchiectasis, asthma Large volume sputum – bronchiectasis Haemoptysis – bronchiectasis, cancer, PVTE Anorexia and weight loss – cancer Ankle swelling – not asthma, cardiac, cor pulmonale Unilateral leg swelling – PVTE Fever, rigors, purulent sputum – pneumonia Pleuritic chest pain – pneumonia, PVTE, pneumothorax

BREATHLESSNESS Exacerbations Yes – asthma, COPD, bronchiectasis Frequency and severity…. .

CHEST PAIN • Respiratory

CHEST PAIN • • Respiratory Cardiac Musculoskeletal Gastrointestinal

CHEST PAIN Site Central – most things Lateral – pneumonia, PVTE, pneumothorax, musculoskeletal Radiation – arm – cardiac - back – most things

CHEST PAIN Type / precipitants Constant / intermittent Effort related – cardiac Pleuritic – pneumonia, PVTE, pneumothorax, musculoskeletal Movement eg arm – musculoskeletal Meals - GI

BRONCHODILATOR THERAPY Concepts of Prevention and regular vs red/brown inhalers LABA, corticosteroid, anti-muscarinic, combinations Relief as required use Blue vs SABA (LABA – formoterol)

BRONCHODILATOR THERAPY MDI Take off cap Shake Breathe out Device to mouth Full breath in and activate as breathing Hold breath for few seconds Repeat Steroid – rinse / gargle afterwards

LONG TERM CORTICOSTEROID THERAPY Benefits – disease control Harms – dose and duration Short term – hunger, dyspepsia, insomnia, acne Long term – weight gain, hypertension, diabetes, pneumonia osteoporosis, skin thinning, cataracts Balance benefit vs harm, aim for lowest effective dose

EXAMINATION

EXAMINATION - PNEUMONECTOMY Affected side Thoracotomy scar Reduced movement / expansion Dull to percussion VF up or down Reduced breath sounds Mediastinum towards the affected side (trachea, apex beat) Differential pleural effusion – mediastinum away from affected side

EXAMINATION COPD/ASTHMA Cyanosis (COPD) Raised respiratory rate Tremor – asterixis if CO 2 retention (COPD) - fine - B-agonist Signs of air trapping due to airway narrowing: reduced cricosternal distance increased A-P diameter of chest (‘barrel’) reduced or lost lateral chest expansion paradoxical lower chest movement reduced / absent cardiac dullness on percussion reduced breath sounds (often mainly apical) Wheeze, insp, exp, but may be absent Sputum pot (COPD, bronchiectasis) Inhalers, Peak Flow meter by the bed

EXAMINATION PULMONARY FIBROSIS Finger clubbing (50%) Cyanosis (if severe) Raised respiratory rate Reduced chest expansion (‘restriction’) Persistent, bi-basal, fine, late inspiratory crackles

SPIROMETRY Restriction – FEV 1 and FVC reduced in parallel ratio normal or increased FEV 1 FVC Ratio 65% predicted 67% 80% Restriction – alveolar disease eg pulmonary fibrosis chest wall disease eg kyphoscoliosis, muscle weakness, obesity

SPIROMETRY Obstruction – FEV 1 reduced more than FVC ratio less than 70% FEV 1 FVC Ratio 65% predicted 80% 64% Obstruction – airway diseases eg asthma, COPD, bronchiectasis

BLOOD GASES Always look at p. H first normal means normal or compensation has occurred PO 2 cannot be interpreted without Fi. O 2

BLOOD GASES Type I respiratory failure low PO 2 only (PCO 2 normal or low and p. H normal) Type II respiratory failure low PO 2 and high PCO 2 p. H may be normal (compensated – HCO 3 will be raised) or reduced

BLOOD GASES Fi. O 2 0. 6 p. H p. O 2 p. CO 2 HCO 3 7. 37 10. 3 3. 1 25 CO 2 + H 2 O H+ + HCO 3

BLOOD GASES Fi. O 2 0. 6 p. H p. O 2 p. CO 2 HCO 3 7. 47 10. 3 3. 1 25

BLOOD GASES Fi. O 2 0. 28 p. H p. O 2 p. CO 2 HCO 3 7. 37 10. 3 8. 4 35

BLOOD GASES Fi. O 2 0. 6 p. H p. O 2 p. CO 2 HCO 3 7. 31 10. 3 8. 4 24

BLOOD GASES Fi. O 2 0. 6 p. H p. O 2 p. CO 2 HCO 3 7. 31 10. 3 8. 4 15